103 related articles for article (PubMed ID: 1828548)
1. Effects of sex steroids on skin 5 alpha-reductase activity in vitro.
Cassidenti DL; Paulson RJ; Serafini P; Stanczyk FZ; Lobo RA
Obstet Gynecol; 1991 Jul; 78(1):103-7. PubMed ID: 1828548
[TBL] [Abstract][Full Text] [Related]
2. In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women.
Arteaga E; Rojas A; Villaseca P; Bianchi M; Arteaga A; Durán D
Menopause; 1998; 5(1):16-23. PubMed ID: 9689190
[TBL] [Abstract][Full Text] [Related]
3. [Receptivity to the sex steroids, physiopathological aspects].
Bercovici JP
Contracept Fertil Sex (Paris); 1984 Jun; 12(6):821-7. PubMed ID: 12313177
[TBL] [Abstract][Full Text] [Related]
4. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
5. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
[TBL] [Abstract][Full Text] [Related]
6. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
Oettel M; Carol W; Gräser T; Klinger G; Mellinger U; Moore C; Schindler AE; Winkler UH
Zentralbl Gynakol; 1997; 119(12):597-606. PubMed ID: 9483810
[TBL] [Abstract][Full Text] [Related]
7. [Preclinical research and development of norethisterone].
Mcguire JL; Hahn DW; Philipps A
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
[TBL] [Abstract][Full Text] [Related]
8. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
9. Steroid hormones and the fertilizing capacity of spermatozoa.
Briggs MH
Steroids; 1973 Oct; 22(4):547-53. PubMed ID: 4127001
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of rat liver delta 4-3-ketosteroid-5 alpha-reductase by steroids in vitro].
Schubert K; Schumann G; Rose G; Ritter F; Strecke J; Schlegel J
Endokrinologie; 1978 May; 72(2):141-8. PubMed ID: 738209
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
Mueck AO; Seeger H; Wallwiener D
Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro.
Rabe T; Kowald A; Ortmann J; Rehberger-Schneider S
Gynecol Endocrinol; 2000 Aug; 14(4):223-30. PubMed ID: 11075290
[TBL] [Abstract][Full Text] [Related]
13. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the potency of orally administered progestins in women.
King RJ; Whitehead MI
Fertil Steril; 1986 Dec; 46(6):1062-6. PubMed ID: 2946605
[TBL] [Abstract][Full Text] [Related]
15. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
Seeger H; Wallwiener D; Mueck AO
Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
[TBL] [Abstract][Full Text] [Related]
16. Vaginal rings for contraception: endocrine parameters.
Olsson SE
Adv Contracept Deliv Syst; 1992; 8(1-2):71-3. PubMed ID: 12285565
[TBL] [Abstract][Full Text] [Related]
17. Comparison of norethindrone and medroxyprogesterone acetate with natural progesterone and estradiol in stimulating prolactin production from cultured endometrial stromal cells.
Levin JH; Tonetta SA; Lobo RA
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1932-8. PubMed ID: 2147816
[TBL] [Abstract][Full Text] [Related]
18. Vasomotor symptoms and estrogen-progestogen therapy.
von Schoultz B
Acta Obstet Gynecol Scand Suppl; 1985; 132():15-8. PubMed ID: 3161264
[No Abstract] [Full Text] [Related]
19. [Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action].
Okada H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):924-8. PubMed ID: 2968780
[TBL] [Abstract][Full Text] [Related]
20. The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
Kamau RK; Maina FW; Kigondu C; Mati JK
East Afr Med J; 1990 Aug; 67(8):550-5. PubMed ID: 2148146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
